Crohn’s Disease Treatment Market, by Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jul 2022

Code : CMI1237

Pages :150

Formats :

Excel and PDF

Industry : Pharmaceutical

Crohn’s Disease Treatment MarketSize and Trends

Global crohn’s disease treatment market is estimated to be valued at US$ 10.92 billion in 2022 and is expected to exhibit a CAGR of 4.2% during the forecast period (2022-2030)

Figure 1.Global Crohn’s Disease Treatment Market Share (%), by Distribution Channel, 2022

Increasing prevalence of inflammatory bowel diseases is expected to drive growth of the crohn’s disease treatment market.

Factors such as increasing number of inflammatory bowel diseases (IBD) as well as rising number of patients suffering from Crohn’s disease is expected to significantly contribute to growth of the Crohn’s disease treatment market. For instance, according to an article published by the Journal BMC Gastroenterology, in May 2021, an illness-death model based on available data was established to project the future prevalence of IBD in Asia, and Iran in particular from 2017 to 2035. As per the results, in 2035, as compared to 2020, the study expected a 2.5-fold rise in prevalence for Iran with 69 thousand cases, a 2.3-fold increment for North Africa and the Middle East with 220 thousand cases, quadrupling of the prevalence for India with 2.2 million cases, a 1.5-fold increase for East Asia region with 4.5 million cases, and a 1.6-fold elevation in prevalence for high‐income Asia‐Pacific and Southeast Asia regions with 183 and 199 thousand cases respectively.

Figure 2.Global Crohn’s Disease Treatment Market Share (%), by Region, 2022

Increasing product launches and development of new and effective therapy options to cure the symptoms of the crohn’s disease are expected to drive market growth during the forecast period.

Development of new and effective therapy options to cure the symptoms of crohn’s disease is also a vital factor contributing to growth of Crohn’s disease treatment market. For instance, researchers from University of Washington Medicine at the Crohn's & Colitis Congress held in January 2018 presented a study that developed an antibiotic, which showed four fold better response on the inflammation of intestine among patients suffering with Crohn’s disease as compared to the existing therapies available in market.